OasisLMS

Release Date: June 6, 2024

Expiration Date: June 5, 2027

This recorded webinar explores the emerging role of virtual reality (VR) in chronic pain management and neuromodulation, highlighting how immersive technologies may enhance patient care, treatment outcomes, and rehabilitation strategies. Expert faculty review the current landscape of VR applications in pain medicine, discuss the opportunities and challenges associated with integrating VR into neuromodulation practices, and examine the growing body of research supporting its use.

Through faculty presentations and discussion, learners will gain a deeper understanding of how VR technologies can complement neuromodulation therapies, improve patient engagement, and support functional restoration. The activity also explores future directions for VR-enhanced neuromodulation and identifies key research opportunities that may shape the next generation of patient-centered pain management approaches.

To access the NANS eLearning Center and register for this content, log in using your NANS account username and password.

• Have a NANS account? Click Login.
• Need an account? Click Create Account and complete the form.
• Questions about your NANS account? Email membership@nans.org or call (773) 648-7845 (Mon–Fri, 8:30 AM–5:00 PM CT).

Pain, neurosurgeons, neurology, pain, residents, fellows, APPs

Following participation in this activity, learners will be able to:

• Describe the Current State of VR in Chronic pain and Neuromodulation
• Identify the potential benefits and challenges of incorporating VR into neuromodulation practices
• Develop future directions and research opportunities in VR-enhanced neuromodulation

Welcome
Yashar Eshraghi, MD

The Current State of VR in Chronic Pain and Neuromodulation
Brennan Spiegel, MD, MSHS

The Potential Benefits and Challenges of Incorporating VR into Neuromodulation Practices
Maged Guirguis, MD

Future Directions and Research Opportunities in VR-Enhanced Neuromodulation
Christine Hunt, DO, MS

None of the planners, staff, reviewers or faculty have any relevant financial relationships to disclose with ACCME ineligible companies except those listed below. All relevant relationships have been mitigated. 

Disclosures